Cytophage Technologies (TSXV:CYTO) Total Liabilities : C$2.24 Mil (As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Cytophage Technologies Total Liabilities?

Cytophage Technologies's Total Liabilities for the quarter that ended in Mar. 2024 was C$2.24 Mil.

Cytophage Technologies's quarterly Total Liabilities declined from Sep. 2023 (C$0.24 Mil) to Dec. 2023 (C$0.05 Mil) but then increased from Dec. 2023 (C$0.05 Mil) to Mar. 2024 (C$2.24 Mil).

Cytophage Technologies's annual Total Liabilities declined from Dec. 2021 (C$0.28 Mil) to Dec. 2022 (C$0.24 Mil) and declined from Dec. 2022 (C$0.24 Mil) to Dec. 2023 (C$0.05 Mil).

Cytophage Technologies Total Liabilities Historical Data

The historical data trend for Cytophage Technologies's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytophage Technologies Total Liabilities Chart

Cytophage Technologies Annual Data

Trend

Dec21

Dec22

Dec23

Total Liabilities

0.28

0.24

0.05

Cytophage Technologies Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial			0.24	-	0.24	0.05	2.24

Cytophage Technologies Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Cytophage Technologies's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.049	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	0.05

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	5.461	-	5.411
	=	0.05

Cytophage Technologies's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.851	+	(1.389	+	2.2204460492503E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	2.24

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	8.745	-	6.505
	=	2.24

Cytophage Technologies Total Liabilities Related Terms

Thank you for viewing the detailed overview of Cytophage Technologies's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Cytophage Technologies (TSXV:CYTO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytophage Technologies Ltd (TSXV:CYTO) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Cytophage Technologies Ltd is a Canadian biotechnology company that uses molecular genetic techniques and synthetic biology to create effective bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria company generates phages to address specific bacterial infections, including strains resistant to antibiotics. It has also developed a 'phage-display' methodology to develop vaccine-like products using bacteriophages for a number of potential applications in human and animal health.